Categories
Zydus Lifesciences Limited — Board Meeting, 19-05-2026: Outcome of Board Meeting
19-05-2026 · 02:09 pm
Zydus Lifesciences announced Q4 & FY26 consolidated results: FY26 net profit at ₹5,040 Cr. Board proposed ₹1/share final dividend. Strategic moves include acquisitions of Amplitude Surgical, Comfort Click, US biologics facilities & signing a deal to acquire Assertio Holdings for ~$166M.
No comments yet. Be the first to comment!